Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

447
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
447
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Principles of Drug Action01:24

Principles of Drug Action

9.4K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor Agonists.

Molecules (Basel, Switzerland)·2025
Same author

Recent applications of computational methods to allosteric drug discovery.

Frontiers in molecular biosciences·2023
Same author

Reassessment of an Innovative Insulin Analogue Excludes Protracted Action yet Highlights the Distinction between External and Internal Diselenide Bridges.

Chemistry (Weinheim an der Bergstrasse, Germany)·2020
Same author

Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides.

Molecules (Basel, Switzerland)·2019
Same author

Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides.

Investigational new drugs·2018
Same author

Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).

Bioorganic & medicinal chemistry letters·2018

Related Experiment Video

Updated: Mar 31, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.

David J Diller1, Jon Swanson2, Alexander S Bayden1

  • 1CMD Bioscience, 5 Science Park, New Haven, CT 06511, USA.

Future Medicinal Chemistry
|October 30, 2015
PubMed
Summary
This summary is machine-generated.

Rational peptide drug design, using computational tools, offers a promising approach for developing new therapeutics targeting challenging intracellular interactions. This method efficiently identifies

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Related Experiment Videos

Last Updated: Mar 31, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Area of Science:

  • Drug discovery and development
  • Computational chemistry
  • Medicinal chemistry

Background:

  • Peptides bridge the gap between small molecules and antibodies for drug development.
  • Intracellular protein-protein interactions remain a significant challenge in drug discovery.
  • Rational design coupled with computational tools can optimize peptide drug candidates.

Purpose of the Study:

  • To review principles and recent advances in rational, computer-enabled peptide drug design.
  • To discuss the impact of physicochemical properties on peptide drug development.
  • To highlight opportunities and challenges in ADME/Tox for peptide therapeutics.

Main Methods:

  • Review of current literature on rational peptide design.
  • Analysis of computational tools for in silico peptide design.
  • Case studies illustrating principles and practices in peptide drug discovery.

Main Results:

  • Computer-aided design accelerates the exploration of chemical space for drug-like peptides.
  • Physicochemical properties significantly influence peptide drug efficacy and safety.
  • Advances in computational tools enhance the identification of viable peptide drug candidates.

Conclusions:

  • Rational, computer-enabled peptide design is a powerful strategy for developing novel therapeutics.
  • Addressing ADME/Tox challenges is crucial for successful peptide drug development.
  • Future applications hold significant promise for targeting previously undruggable targets.